XML 33 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Other Operating Income (Expense), net
 9 Months Ended
Sep. 30, 2025
Unusual or Infrequent Items, or Both [Abstract]  
Other Operating Income (Expense), net Other Operating Income (Expense), net
We have recorded incurred charges or realized benefits that we believe are significant to our current operating results warranting separate classification in other operating income (expense), net within our unaudited condensed consolidated statements of operations.
Three Months EndedNine Months Ended
September 30, 2025September 30, 2024September 30, 2025September 30, 2024
(In millions)
Restructuring(1)
Employee-related charges$(0.9)$(2.2)$(9.2)$(1.1)
Asset abandonment and other restructuring costs(0.4)(21.9)(20.1)(21.9)
Intangible and tangible asset impairments, excluding goodwill(2)
(273.9)— (273.9)— 
Gains (losses) on disposals and other(1)
— (41.7)2.9 (36.4)
Other operating income (expense), net$(275.2)$(65.8)$(300.3)$(59.4)
(1)During the third quarter of 2024, we made the decision to wind down or sell certain of our U.S. craft businesses and related facilities and recorded employee-related and asset abandonment charges, including accelerated depreciation in excess of normal depreciation. In addition, during the third quarter of 2024, we recognized a loss of $41.1 million related to the disposal of the sold businesses. During the first quarter of 2025, we incurred incremental accelerated depreciation in excess of normal depreciation of $17.9 million. Restructuring charges related to these actions are substantially complete and any remaining future charges are expected to be immaterial.
(2)During the third quarter of 2025, we recognized a partial impairment charge of $198.6 million related to the Staropramen family of brands indefinite-lived intangible asset in our EMEA&APAC segment. Also during the third quarter of 2025, we recognized a full impairment charge of $75.3 million related to the Blue Run Spirits definite-lived intangible asset in our Americas segment. See Part I.—Item 1. Financial Statements, Note 5, "Goodwill and Intangible Assets" for further information.